BSE filing, NSE: CORALAB. Summary written from the filing by ALFA Finder's alert engine.
Coral Laboratories Ltd: key numbers
- Share price
- ₹501.40
- Market cap
- ₹179.1 Cr
- Revenue (annual)
- ₹85.90 Cr
- Net profit (annual)
- ₹16.38 Cr
- P/E (TTM)
- 9.3×Sector 46.1×
- Promoter holding
- 71.51%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Coral Laboratories Ltd
All →Coral Laboratories Other Announcement
The company has filed its quarterly shareholding pattern statement for the quarter ended September 30, 2026, as required under SEBI Regulation 31.
Coral Laboratories Annual General Meeting
Coral Laboratories Limited held its 44th Annual General Meeting on September 29, 2026. Shareholders approved the FY2025-26 audited financial statements, declared a final dividend, and re-appointed retiring directors.
Coral Laboratories Board Meeting Date
Coral Laboratories intimated BSE of a board meeting scheduled for 25 September 2026. The agenda includes approval of the cost audit report for FY 2025-26.
Coral Laboratories Annual General Meeting
Coral Laboratories Limited has issued a notice for its Annual General Meeting scheduled for June 29, 2026. Agenda items include adoption of financial statements and dividend declaration.
Coral Laboratories Annual Report
Coral Laboratories Limited has released its Annual Report for FY 2025-26. The 44th Annual General Meeting is scheduled for September 29, 2026, via video conferencing.
Coral Laboratories Annual General Meeting
Coral Laboratories Ltd has scheduled its 44th Annual General Meeting for September 29, 2026. The company has also fixed the book closure dates and record date for final dividend.
Other board meeting outcome announcements
All →R R Kabel Board Meeting Outcome
RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.
M K Exim (India) Board Meeting Outcome
M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.
United Spirits Board Meeting Outcome
United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.
SBI Funds Management Board Meeting Outcome
SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.
- Execution
- April 1, 2028 to March 31, 2030
Paras Healthcare Board Meeting Outcome
Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.
Gateway Distriparks Board Meeting Outcome
Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.